IM injections ensure quick absorption and are preferred in clinical settings
Figure 2 shows a typical example of the effects of 100 nM exendin-4 on an IML neuron at the Th2 level
Sources Consulted Secondary data for the market study was gathered from multiple credible sources, including: Government databases, regulatory bodies, and public institutions International organizations (WHO, OECD, IMF, World Bank, etc.) Commercial and paid databases Industry associations, trade publications, and technical journals Company annual reports, investor presentations, press releases, and SEC filings Academic research papers, patents, and scientific literature Previous market research publications and syndicated reports These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights
All GLP-1s are clinically-tested, stimulant-free, and non-habit forming